Literature DB >> 22470592

Cavitating lung lesions in chronic thromboembolic pulmonary hypertension.

Heather Harris1, Richard Barraclough, Christine Davies, Iain Armstrong, David G Kiely, Edwin van Beek.   

Abstract

PURPOSE: The aim of this study is to assess the incidence and natural history of cavitating lung lesions in chronic thromboembolic pulmonary hypertension (CTEPH), note thrombus position between patients with and without a cavity and determine whether their development is a predictor of mortality. MATERIALS #ENTITYSTARTX00026;
METHODS: All patients with confirmed CTEPH attending our Pulmonary Vascular Unit between February 1998 and January 2006 were identified, and a review of their notes and imaging was performed. Thrombus position, pre-disposing factors, cavity progression and mortality were noted, and comparisons made between those with and without a cavity.
RESULTS: 11 of 104 patients had a cavity (10.6%). Thrombus distribution was similar between those with and those without a cavity. Preceding infection was not proven in most cases. 27.3% of patients with a cavity died compared to 26.8% of those without.
CONCLUSION: Cavity formation in CTEPH is 3 times more common than in acute pulmonary embolism. Thrombus position does not predict cavity development, and the presence of a cavity may serve as an indicator of disease severity but does not appear to predict mortality.

Entities:  

Year:  2008        PMID: 22470592      PMCID: PMC3303257          DOI: 10.3941/jrcr.v2i3.50

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  19 in total

Review 1.  Small-vessel diseases of the lung: CT-pathologic correlates.

Authors:  David M Hansell
Journal:  Radiology       Date:  2002-12       Impact factor: 11.105

2.  A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension.

Authors:  Roald J Roeleveld; J Tim Marcus; Anco Boonstra; Pieter E Postmus; Koen M Marques; Jean G F Bronzwaer; Anton Vonk-Noordegraaf
Journal:  J Magn Reson Imaging       Date:  2005-07       Impact factor: 4.813

3.  Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience.

Authors:  Konstantin Nikolaou; Stefan O Schoenberg; Ulrike Attenberger; Juergen Scheidler; Olaf Dietrich; Bernd Kuehn; Frank Rosa; Armin Huber; Hanno Leuchte; Rainer Baumgartner; Juergen Behr; Maximilian F Reiser
Journal:  Radiology       Date:  2005-07-01       Impact factor: 11.105

4.  Pulmonary cavitation following pulmonary infarction.

Authors:  L S Libby; T E King; F M LaForce; M I Schwarz
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

5.  Pulmonary infarction presenting as aseptic cavitation.

Authors:  Y Q Bao; L R Jin; W C Chen
Journal:  Chin Med J (Engl)       Date:  1990-08       Impact factor: 2.628

Review 6.  Cavitary pulmonary infarct in immunocompromised hosts.

Authors:  T I Morgenthaler; J H Ryu; J P Utz
Journal:  Mayo Clin Proc       Date:  1995-01       Impact factor: 7.616

7.  The radiology of aseptic cavitation in pulmonary infarction.

Authors:  A G Wilson; A E Joseph; R J Butland
Journal:  Clin Radiol       Date:  1986-07       Impact factor: 2.350

8.  Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

Authors:  I Chazova; J E Loyd; V S Zhdanov; J H Newman; Y Belenkov; B Meyrick
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

9.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

10.  Factors that influence the outcome of primary pulmonary hypertension.

Authors:  A Rozkovec; P Montanes; C M Oakley
Journal:  Br Heart J       Date:  1986-05
View more
  6 in total

1.  A Case Report: Cavitary Infarction Caused by Pulmonary Tumor Thrombotic Microangiopathy in a Patient with Pancreatic Intraductal Papillary Mucinous Neoplasm.

Authors:  Kyoungkyg Bae; Woon-Jung Kwon; Seong Hoon Choi; Jong Hwa Lee; Hee Jeong Cha
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

2.  Lobar Necrosis from Pulmonary Embolism.

Authors:  Ramiro Fernandez; Jonathan M Tomasko; Daphne Edgren; Ankit Bharat
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

Review 3.  Complications of pulmonary hypertension: a pictorial review.

Authors:  Sze M Mak; Nicola Strickland; Deepa Gopalan
Journal:  Br J Radiol       Date:  2016-12-07       Impact factor: 3.039

4.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

5.  Lung Cavities in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Caio Julio Cesar Dos Santos Fernandes; Ellen Pierre de Oliveira; Willian Salibe-Filho; Mario Terra-Filho; Carlos Vianna Poyares Jardim; Luciana Tamie Kato-Morinaga; Susana Hoette; Rogerio de Souza
Journal:  Clinics (Sao Paulo)       Date:  2020-01-10       Impact factor: 2.365

6.  Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients.

Authors:  Jan Matthias Kruse; Daniel Zickler; Willie M Lüdemann; Sophie K Piper; Inka Gotthardt; Jana Ihlow; Selina Greuel; David Horst; Andreas Kahl; Kai-Uwe Eckardt; Sefer Elezkurtaj
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.